US Broker Ratings

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Exploring a 22% Potential Upside for Investors

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, is capturing investor attention with its innovative approach to drug delivery and a promising..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking a 135% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), an innovative player in the biopharmaceutical sector, has captured investor attention with its robust pipeline of radiopharmaceutical products and a significant..

Masimo Corporation (MASI) Stock Analysis: Unlocking a Potential 32.82% Upside in the Healthcare Sector

Masimo Corporation (MASI), a prominent player in the medical devices industry, is catching the eye of investors with its promising potential upside of 32.82%. This Irvine,..

Glaukos Corporation (GKOS): Investor Outlook and Key Metrics Highlighting a Promising 11.98% Upside

Glaukos Corporation (NYSE: GKOS) stands at the forefront of innovative solutions in the ophthalmic medical device sector, making it a fascinating prospect for investors within the..

Humana Inc. (HUM) Investor Outlook: Exploring a 7.45% Potential Upside in Healthcare Plans

Humana Inc. (NYSE: HUM), a prominent player in the healthcare plans sector, is drawing considerable interest from investors with its solid performance and strategic positioning in..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook on a Booming Biotech with 362% Revenue Growth

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) has captured the attention of investors in the healthcare sector with its remarkable revenue growth and its strategic focus on developing..

Roivant Sciences (ROIV) Stock Analysis: A Promising Biotech with a 16% Upside Potential

Roivant Sciences Ltd. (NASDAQ: ROIV), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with a market capitalization of $15.37 billion. Based in London,..

argenx SE (ARGX) Stock Analysis: A Biotech Powerhouse with a 15% Upside Potential

argenx SE (ARGX), a prominent player in the biotechnology sector, commands significant attention with its cutting-edge therapies for autoimmune diseases. Based in Amsterdam, Netherlands, this commercial-stage..

Stevanato Group S.p.A. (STVN) Investor Outlook: 37.56% Potential Upside Captures Attention

Italy-based Stevanato Group S.p.A. (NYSE: STVN) is making waves in the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of..

BioNTech SE (BNTX) Stock Analysis: Navigating a 46.33% Potential Upside in the Biotechnology Sector

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has captured the attention of investors with a significant potential upside of 46.33%, according to..

Solventum Corporation (SOLV) Stock Analysis: Evaluating the 1.67% Potential Upside in Healthcare

Solventum Corporation (SOLV), a prominent player in the healthcare sector, has drawn significant attention from investors due to its comprehensive portfolio of medical instruments and supplies...

Hologic, Inc. (HOLX) Investor Outlook: Stability in Women’s Health Sector with Modest Upside

Hologic, Inc. (NASDAQ: HOLX), a formidable player in the healthcare sector, commands attention with its robust portfolio of diagnostics, medical imaging systems, and surgical products tailored..

CVS Health Corporation (CVS) Stock Analysis: Unpacking an 18% Upside Potential for Investors

CVS Health Corporation (NYSE: CVS) is a major player in the healthcare sector, commanding a market capitalization of $100.82 billion. As a multifaceted healthcare company, CVS..

Revolution Medicines, Inc. (RVMD) Stock Analysis: A Biotech Powerhouse with 21 Buy Ratings and a Promising Pipeline

Revolution Medicines, Inc. (NASDAQ: RVMD) is capturing the attention of investors with its innovative approach to tackling RAS-addicted cancers, a notoriously challenging area in oncology. With..

Doximity, Inc. (DOCS) Stock Analysis: Evaluating a 55.64% Potential Upside in the Health Information Sector

As the healthcare industry continues to evolve, digital platforms like Doximity, Inc. (NYSE: DOCS) are playing an increasingly pivotal role. With a current market capitalization of..

Exact Sciences Corporation (EXAS) Stock Analysis: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a leading player in the healthcare sector, has captured investor attention with its innovative approach to cancer diagnostics and screening. With..

Avantor, Inc. (AVTR) Stock Analysis: Navigating Potential Upside Amidst Revenue Challenges

Avantor, Inc. (AVTR), a key player in the healthcare sector, operates within the medical instruments and supplies industry, providing invaluable mission-critical products and services across a..

Incyte Corporation (INCY): Analyst Ratings Highlight Growth Potential Amid Market Volatility

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, is making headlines with its strong financial performance and promising pipeline of therapeutic products. With..

Waters Corporation (WAT) Stock Analysis: A Healthcare Giant with a 2.43% Potential Upside

Waters Corporation (NYSE: WAT), a stalwart in the healthcare sector, continues to be a significant player in the diagnostics and research industry. With a market capitalization..

Teva Pharmaceutical (TEVA) Stock Analysis: Exploring Growth Potential Amidst Robust Analyst Ratings

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) is a prominent player in the global pharmaceutical landscape, primarily recognized for its expansive portfolio of generic and specialty medicines...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds